Login to Your Account

Idenix Stock Tumbles on Mixed Clinical Program Updates

By Marie Powers

Friday, February 11, 2011
Idenix Pharmaceuticals Inc. provided updates to three key clinical development programs on Wednesday. Unfortunately for investors, two were disappointments, though one of those might ultimately have a silver lining for the Cambridge, Mass.-based company.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription